Duloxetine
Product Images NDC 55700-727

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 55700-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (New Doc 2019 03 04 09.46.30)

This is a description of a medication called DULOXETINE DR 20 MG, marketed by Ajanta Pharma USA Inc. It is packaged in a white/blue capsule and contains enteric-coated pellets of 22.4 mg of Duloxetine Hydrochloride USP equivalent to 20 mg Duloxetine. The medication should be stored at controlled temperature, 59-86 degrees F, and kept out of children's reach. Consultation with a physician or seeing the insert for dosage is recommended. The text also includes a warning, a phone number, and serial and expiration dates, among other details related to packaging.*

FDA Label Image

Figure01 (Duloxetine Fig01)

This is a graph showing the proportion of patients with relapse over time from randomization to relapse (in days) for both a placebo group and a group treated with Duloxetine. The values shown on the graph are 0, 50, 100, 150, 200, and 250.*

FDA Label Image

Figure2 (Duloxetine Fig02)

The graph displays the proportion of patients who experienced a relapse under treatment with placebo and Duloxetine over time from randomization to relapse, measured in days. The vertical axis ranges from 0 to 10, and the horizontal axis ranges from 0 to 300.*

FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

This is a chart showing the effectiveness of Duloxetine for pain relief. The dosage is either 60 mg or 120 mg, taken once daily as a placebo. The chart shows a percent improvement in pain from baseline. Non-available is needed for further explanation as there is not enough data to describe where this chart comes from or what it exactly means.*

FDA Label Image

Figure08 (Duloxetine Fig08)

The text describes a clinical trial comparing the effects of Placebo and Duloxetine 60mg taken once daily on pain relief. There is a graph showing "Percent Improvement in Pain from Baseline (BOCF)" over a range from 0-100%. However, the rest of the text has distortions that make it unclear and not-readable.*

FDA Label Image

Figure09 (Duloxetine Fig09)

This appears to be a chart or table showing the effects of a drug called Duloxetine on pain levels. The dosage is either 60 or 120 mg once daily, and there are percentages indicating improvement in pain levels from baseline after taking the drug. There are also some symbols and numbers that are not clear, so further information cannot be determined.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.